7:00 am

REGISTRATION & NETWORKING BREAKFAST

 

7:30 am

LONGWOOD FUND INTRODUCTION

Vikas Goyal, Venture Partner, Longwood Fund

​​​

8:00 am

BIG BIOPHARMA PIPELINE SOURCING

Wendy Bartie, SVP, US Oncology & Hematology, BMS

Paris Panayiotopoulos, Senior Managing Director, Blackstone Life Sciences

David Redfern, President, Corporate Development, GSK

​Moderator: Vikas Goyal, Venture Partner, Longwood Fund

​

8:30 am

ADVANCING THE TRANSLATION OF BIOMEDICAL RESEARCH

Theresa Heah, CEO, Paratus Sciences

Don Ingber, Founding Director, Wyss Institute, Harvard University​

Anissa Kalinowski, CEO, Halo Biosciences

Bali Pulendran, Professor & Director, Institute for Immunity, Transplantation, & Infectious Disease, Stanford University

Moderator: Kara Carter, EIR, Evotec

​

9:00 am

FIRESIDE CHAT

Marc Tessier-Lavigne, CEO, Xaira
Irv Weissman, Director, Institute of Stem Cell Biology & Regenerative Medicine, Stanford

​

9:20 am

DEVELOPING GLOBAL PARTNERSHIPS

Meeta Chatterjee, Chief Strategy Officer, Sun Pharma

Philippe Lopes-Fernandes, CBO, Ipsen

Thomas Mehrling, CEO, Helix BioPharma

Zhen Su, CEO, Marengo Therapeutics

Moderator: Daniel Palmacci, President, Cell & Gene, Lonza

 

9:55 am

NETWORKING BREAK

 

10:20 am

ACCELERATING DRUG DEVELOPMENT

Anirvan Ghosh, CEO, Unity Biotechnology

Carl Hansen, CEO, AbCellera

Shiva Malek, Global Head, Oncology, Novartis BioMedical Research

Phil Vickers, CEO, Solu Therapeutics

Moderator: Lisa Ricciardi, CEO, Cognition Therapeutics 

​

10:50 am

R&D COLLABORATION

Wolfram Carius, EVP, Cell & Gene Therapy, Bayer Pharmaceuticals

Ruxandra Draghia-Akli, EVP, Head, R&D, Novavax

Julie Gerberding, CEO, Foundation for the NIH 

Ryan Richardson, Chief Strategy Officer, BioNTech

Moderator: Ken Drazan, CEO, ArsenalBio

​

11:20 am

IMPACT & IMPORTANCE OF COMPANY CULTURE

Meg Alexander, President & COO, Ovid Therapeutics

Jeb Keiper, CEO, Nimbus Therapeutics

Mathai Mammen, CEO, Parabalis Medicines

Joanne Smith-Farrell, CEO, Be Bio

Moderator: Smita Pillai, SVP, Talent Development, Inclusion & Innovation Culture, Regeneron

​

11:50 am

FIRESIDE CHAT

Eliav Barr, CMO & Head, Global Clinical Development, Merck Research Laboratories

Teresa Graham, CEO, Roche Pharma

​

12:10 pm

NETWORKING LUNCHEON

 

1:00 pm

DRUG DISCOVERY SCIENCES

Dee Datta, CEO, Switch Therapeutics

Raj Devraj, CEO, Rectify Pharmaceuticals

JJ Kang, CEO, Appia Bio

Dominique Verhelle, CEO, NextRNA Therapeutics

Moderator: Yiannis Kiachopoulos, CEO, Causaly

​

1:30 pm

ADVANCES IN CLINICAL TRIALS

Michael Amoroso, CEO, Precision BioSciences

Sandi Dunn, CEO, Phoenix Molecular Designs
Paulo Fontoura, CMO, Xaira

Jim Wooldridge, CMO, Immunitas Therapeutics

Moderator: Greg Licholai, Chief Medical and Innovation Officer, ICON

 

2:00 pm

INNOVATIVE COMMERCIAL MODELS

Matic Meglic, Global Executive Director, Industry Partnerships, Novartis

Kabir Nath, CEO, COMPASS Pathways 

Ram Palanki, CCO, REGENXBIO

Moderator: Steve Blaising, Chairman & Co-Founder, Brain Surgery Worldwide

​

2:30 pm

M&A AND DEAL-MAKING LANDSCAPE

Susan Hill, CEO, Mestag Therapeutics

Daphne Karydas, President & CFO, Flare Therapeutics

Konstantina Katcheves, SVP, Innovative Medicines BD, Teva

Matthias Müllenbeck, SVP, Global Head, BD & Alliance Management, EMD Serono

Moderator: Jennifer Giottonini Cayer, CBO, Pulmocide

​

3:00 pm

NETWORKING BREAK

 

3:30 pm

REGULATORY KEYNOTE

Peter Marks, Director, CBER, FDA

 

4:00 pm

RARE DISEASE INNOVATION

Peter Ghoroghchian, CEO, Latus Bio

Oscar Izeboud, CEO, Scenic Biotech

Shalini Sharp, Board Chair, Mahzi Therapeutics

Tamar Thompson, Head, Global Corporate Affairs, Alexion

Moderator: Preston Taylor, CFO, Greater Than One

 

4:30 pm

FINANCING INNOVATION

Lovisa Afzelius, General Partner, Flagship Pioneering 

Frank Nestle, Partner & CEO, Deerfield Discovery and Development

Vijay Pande, General Partner, a16z

Ursheet Parikh, Partner, Mayfield

​Moderator: Jonas Grossman, Managing Partner & President, Chardan

​

5:00 – 7:00 pm

COCKTAIL RECEPTION